Cargando…
Image-guided percutaneous ablation for the treatment of lung malignancies: current state of the art
Image-guided percutaneous lung ablation has proven to be a valid treatment alternative in patients with early-stage non-small cell lung carcinoma or oligometastatic lung disease. Available ablative modalities include radiofrequency ablation, microwave ablation, and cryoablation. Currently, there are...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8085189/ https://www.ncbi.nlm.nih.gov/pubmed/33914187 http://dx.doi.org/10.1186/s13244-021-00997-5 |
_version_ | 1783686281605152768 |
---|---|
author | Páez-Carpio, Alfredo Gómez, Fernando M. Isus Olivé, Gemma Paredes, Pilar Baetens, Tarik Carrero, Enrique Sánchez, Marcelo Vollmer, Ivan |
author_facet | Páez-Carpio, Alfredo Gómez, Fernando M. Isus Olivé, Gemma Paredes, Pilar Baetens, Tarik Carrero, Enrique Sánchez, Marcelo Vollmer, Ivan |
author_sort | Páez-Carpio, Alfredo |
collection | PubMed |
description | Image-guided percutaneous lung ablation has proven to be a valid treatment alternative in patients with early-stage non-small cell lung carcinoma or oligometastatic lung disease. Available ablative modalities include radiofrequency ablation, microwave ablation, and cryoablation. Currently, there are no sufficiently representative studies to determine significant differences between the results of these techniques. However, a common feature among them is their excellent tolerance with very few complications. For optimal treatment, radiologists must carefully select the patients to be treated, perform a refined ablative technique, and have a detailed knowledge of the radiological features following lung ablation. Although no randomized studies comparing image-guided percutaneous lung ablation with surgery or stereotactic radiation therapy are available, the current literature demonstrates equivalent survival rates. This review will discuss image-guided percutaneous lung ablation features, including available modalities, approved indications, possible complications, published results, and future applications. |
format | Online Article Text |
id | pubmed-8085189 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-80851892021-05-05 Image-guided percutaneous ablation for the treatment of lung malignancies: current state of the art Páez-Carpio, Alfredo Gómez, Fernando M. Isus Olivé, Gemma Paredes, Pilar Baetens, Tarik Carrero, Enrique Sánchez, Marcelo Vollmer, Ivan Insights Imaging Educational Review Image-guided percutaneous lung ablation has proven to be a valid treatment alternative in patients with early-stage non-small cell lung carcinoma or oligometastatic lung disease. Available ablative modalities include radiofrequency ablation, microwave ablation, and cryoablation. Currently, there are no sufficiently representative studies to determine significant differences between the results of these techniques. However, a common feature among them is their excellent tolerance with very few complications. For optimal treatment, radiologists must carefully select the patients to be treated, perform a refined ablative technique, and have a detailed knowledge of the radiological features following lung ablation. Although no randomized studies comparing image-guided percutaneous lung ablation with surgery or stereotactic radiation therapy are available, the current literature demonstrates equivalent survival rates. This review will discuss image-guided percutaneous lung ablation features, including available modalities, approved indications, possible complications, published results, and future applications. Springer International Publishing 2021-04-29 /pmc/articles/PMC8085189/ /pubmed/33914187 http://dx.doi.org/10.1186/s13244-021-00997-5 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Educational Review Páez-Carpio, Alfredo Gómez, Fernando M. Isus Olivé, Gemma Paredes, Pilar Baetens, Tarik Carrero, Enrique Sánchez, Marcelo Vollmer, Ivan Image-guided percutaneous ablation for the treatment of lung malignancies: current state of the art |
title | Image-guided percutaneous ablation for the treatment of lung malignancies: current state of the art |
title_full | Image-guided percutaneous ablation for the treatment of lung malignancies: current state of the art |
title_fullStr | Image-guided percutaneous ablation for the treatment of lung malignancies: current state of the art |
title_full_unstemmed | Image-guided percutaneous ablation for the treatment of lung malignancies: current state of the art |
title_short | Image-guided percutaneous ablation for the treatment of lung malignancies: current state of the art |
title_sort | image-guided percutaneous ablation for the treatment of lung malignancies: current state of the art |
topic | Educational Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8085189/ https://www.ncbi.nlm.nih.gov/pubmed/33914187 http://dx.doi.org/10.1186/s13244-021-00997-5 |
work_keys_str_mv | AT paezcarpioalfredo imageguidedpercutaneousablationforthetreatmentoflungmalignanciescurrentstateoftheart AT gomezfernandom imageguidedpercutaneousablationforthetreatmentoflungmalignanciescurrentstateoftheart AT isusolivegemma imageguidedpercutaneousablationforthetreatmentoflungmalignanciescurrentstateoftheart AT paredespilar imageguidedpercutaneousablationforthetreatmentoflungmalignanciescurrentstateoftheart AT baetenstarik imageguidedpercutaneousablationforthetreatmentoflungmalignanciescurrentstateoftheart AT carreroenrique imageguidedpercutaneousablationforthetreatmentoflungmalignanciescurrentstateoftheart AT sanchezmarcelo imageguidedpercutaneousablationforthetreatmentoflungmalignanciescurrentstateoftheart AT vollmerivan imageguidedpercutaneousablationforthetreatmentoflungmalignanciescurrentstateoftheart |